MedTrace Logo

MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

NCT00533208 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 766

Last updated 2015-12-22

No results posted yet for this study

Summary

To assess the efficacy of MK0524 on seasonal allergies.

Conditions

  • Seasonal Allergies

Interventions

DRUG

MK0524

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Primary Completion
2003-10-31
Completion
2003-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00533208 on ClinicalTrials.gov